医学
勃起功能障碍
性欲
安慰剂
睾酮(贴片)
性功能障碍
胶囊
泌尿科
性功能
性欲减退
前列腺
内科学
不利影响
病理
生物
植物
替代医学
癌症
作者
Huihui Zhang,Shidong Deng,L.-Z. Liu,Yurou Wang,Kuilin Fei
出处
期刊:Medicine
[Wolters Kluwer]
日期:2025-01-03
卷期号:104 (1): e41160-e41160
被引量:2
标识
DOI:10.1097/md.0000000000041160
摘要
This study aimed to assess the efficacy and safety of Fufang Xuanju capsule in males with late-onset hypogonadism (LOH) complaining of sexual dysfunction during 3 months period. We identified the patients through questionnaires and laboratory examinations. Patients in the treatment group (n = 57) and placebo group (n = 50) received Fufang Xuanju capsules (3.78 g) or placebo capsules daily for 3 months, respectively. After treatment, the plasma total testosterone of both groups sustained, however, libido and erectile dysfunction in patients of the treatment group but not placebo group were significantly improved, measured by elevated scores of International Index of Erectile Function-5. The overall efficacy rate of Fufang Xuanju capsule for LOH was 71.9%. The most striking clinical effects were observed in patients exhibiting mild and moderate erectile dysfunction. No severe adverse effects were observed during the period of study. The remaining parameters such as total prostate-specific antigen, prostate volume and uroflow rate remained stable. Fufang Xuanju capsule proves to be an effective and safe treatment in a short time to alleviate symptoms of sexual dysfunction in LOH patients, especially in those exhibiting mild and moderate erectile dysfunction. Little effect on the level of total testosterone makes it well suitable for LOH patients which have contraindications of testosterone replacement therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI